Delivery Order SPE2DB22D9309-SPE2DB25FAE63

Award Date 3/14/25
Potential Completion Date 4/4/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,906.30 contract is for the supply of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $80,886.40 order is for the supply of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a prescription pharmaceutical product. The award is made under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue delivery orders for a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $54,432.80 fixed-price contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, with a performance period ending on November 25, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,540.68 firm fixed-price contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $3,940.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, which has a completion date of July 18, 2024, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product used to treat certain medical conditions. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,880.88 contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a wide range of branded and generic...
This is a $32,298.25 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the medication Eylea 2 mg/0.05 ml syringe, 0.05 ml, and does not have a set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,338.24, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML to the DLA. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $97,979.04, is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,512.00 delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
  • SPE2DB22D9309
    Indefinite Delivery Contract
  • SPE2DB22D9309-SPE2DB25FAE63
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,981.26 contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities.

The contract is not associated with any set-aside designations. However, DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 6/13/25, 10:04 AM